Alnylam Pharmaceuticals, Inc. (ALNY) has a market capitalization of $45.01B and trades at $339.41. The 52-week range is 205.87-495.55.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 142, Earnings Per Share (EPS) of $2.39, annual revenue of $3.71B.
The stock has a beta of 0.38, operates in the Healthcare sector.
